verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: exela pharma sciences, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler exela pharma sciences, llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
EXELA PHARMA SCIENCES, LLC

Identifiers & Regulatory

Product NDC 51754-0203
Product ID 51754-0203_d053ac54-7922-4e79-a5a2-62eb3c2c3f4d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018925
Listing Expiration 2026-12-31
Marketing Start 2016-04-22

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 517540203
Hyphenated Format 51754-0203

Supplemental Identifiers

RxCUI
1665057 1665061
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number NDA018925 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 5 VIAL in 1 CARTON (51754-0203-2) / 2 mL in 1 VIAL
  • 25 VIAL in 1 CARTON (51754-0203-4) / 2 mL in 1 VIAL
source: ndc

Packages (2)

51754-0203-2 5 VIAL in 1 CARTON (51754-0203-2) / 2 mL in 1 VIAL 51754-0203-4 25 VIAL in 1 CARTON (51754-0203-4) / 2 mL in 1 VIAL

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "d053ac54-7922-4e79-a5a2-62eb3c2c3f4d", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["eff5e83b-f819-4a5b-9746-12bce328d7a7"], "manufacturer_name": ["EXELA PHARMA SCIENCES, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (51754-0203-2)  / 2 mL in 1 VIAL", "package_ndc": "51754-0203-2", "marketing_start_date": "20160422"}, {"sample": false, "description": "25 VIAL in 1 CARTON (51754-0203-4)  / 2 mL in 1 VIAL", "package_ndc": "51754-0203-4", "marketing_start_date": "20161209"}], "brand_name": "Verapamil Hydrochloride", "product_id": "51754-0203_d053ac54-7922-4e79-a5a2-62eb3c2c3f4d", "dosage_form": "INJECTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51754-0203", "generic_name": "Verapamil Hydrochloride", "labeler_name": "EXELA PHARMA SCIENCES, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "NDA018925", "marketing_category": "NDA", "marketing_start_date": "20160422", "listing_expiration_date": "20261231"}